MedWatch

Analyst predicts that covid-19 will still affect Demant

On Tuesday morning, Demant will present its interim management statement for Q1, in which it is expected that corona will play a significant role. The firm will also report on the reception of Oticon More.

Demant CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH

Covid-19, increasing infection rates and restrictions in many markets will keep being significant in Danish hearing aid firm Demant's communication when the firm presents its interim management statement for Q1 early on Tuesday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs